Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
Clinical and Translational Gastroenterology
Volume 9, Issue 6, Pages -
Publisher
Springer Nature
Online
2018-06-28
DOI
10.1038/s41424-018-0034-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
- (2017) Mei Zhou et al. JOURNAL OF HEPATOLOGY
- The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health
- (2016) Mary Rinella et al. HEPATOLOGY
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents
- (2016) Farooq H. Khan et al. Obesity
- Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules
- (2016) Bryan L. Copple et al. PHARMACOLOGICAL RESEARCH
- Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice
- (2016) Anuradha Rao et al. Science Translational Medicine
- Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease
- (2015) Arun J. Sanyal DIGESTIVE DISEASES
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice
- (2015) Andriy Myronovych et al. Obesity
- FXR is a molecular target for the effects of vertical sleeve gastrectomy
- (2014) Karen K. Ryan et al. NATURE
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner
- (2013) Andriy Myronovych et al. Obesity
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
- (2012) Thuy-Anh Le et al. HEPATOLOGY
- Bariatric Surgery: Risks and Rewards
- (2008) Walter J. Pories JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation